EDAP TMS raises $40M in stock offering to fund operations
What's the deal? Medical device maker EDAP TMS SADealroom has a profile for this one. Try Dealroom → has raised $40,018,750 through a public offering of American Depositary Shares (ADSs). The company sold 8,425,000 ADSs at $4.75 each, with an expected close of August 14, 2026.
The details: Each ADS represents one ordinary share with a nominal value of €0.13. TD Securities (USA) LLC and Mizuho Securities USA LLC acted as representatives for the underwriters, which carry a 30-day option to buy up to 1,263,750 additional ADSs.
What's the endgame? EDAP plans to use the proceeds for operating costs, capital expenditures, and general corporate purposes, including working capital. The raise strengthens the company's balance sheet as it pursues its strategic plans.
What could go wrong? The offering is dilutive to existing shareholders, lifting the total share count by up to 9,688,750 ADSs if the underwriters exercise their option in full. Executive officers and directors have signed 90-day lock-up agreements restricting the sale of their shares.
The signal: At roughly $40 million, the raise sits in the smaller tier of post-IPO equity deals — enough to extend operations and fund near-term plans, but modest in scale. For EDAP, the move reflects a common playbook: tapping public markets to shore up liquidity rather than turning to fresh private capital.
Read more: MiniChart
Image credit: U.S. Department of Defense
